Open access · CC-BY
via OpenAlex
Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes
Michail Michailidis, Despina Μoraitou, Despina Α. Tata, Kallirhoe Kalinderi, Theodora Papamitsou, Vasileios T. Papaliagkas
International Journal of Molecular Sciences · 2022 · ▲ 327 citations
Deregulated nutrient-sensing
Mitochondrial dysfunction
Altered intercellular communication
Chronic inflammation
Human
Review
Abstract
Globally, the incidence of type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD) epidemics is increasing rapidly and has huge financial and emotional costs. The purpose of the current review article is to discuss the shared pathophysiological connections between AD and T2DM. Research findings are presented to underline the vital role that insulin plays in the brain's neurotransmitters, homeostasis of energy, as well as memory capacity. The findings of this review indicate the existence of a mechanistic interplay between AD pathogenesis with T2DM and, especially, disrupted insulin signaling. AD and T2DM are interlinked with insulin resistance, neuroinflammation, oxidative stress, advanced glycosylation end products (AGEs), mitochondrial dysfunction(definition) and metabolic syndrome. Beta-amyloid, tau protein and amylin can accumulate in T2DM and AD brains. Given that the T2DM patients are not routinely evaluated in terms of their cognitive status, they are rarely treated for cognitive impairment. Similarly, AD patients are not routinely evaluated for high levels of insulin or for T2DM. Studies suggesting AD as a metabolic disease caused by insulin resistance in the brain also offer strong support for the hypothesis that AD is a type 3 diabetes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms23052687
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Michailidis, M., Μoraitou, D., Tata, D.�., Kalinderi, K., Papamitsou, T., & Papaliagkas, V.T. (2022). Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms23052687
Vancouver
Michailidis M, Μoraitou D, Tata D�, Kalinderi K, Papamitsou T, Papaliagkas VT. Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes. International Journal of Molecular Sciences. 2022. doi:10.3390/ijms23052687.
BibTeX
@article{michail2022Alzhei,
title = {Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes},
author = {Michail Michailidis and Despina Μoraitou and Despina Α. Tata and Kallirhoe Kalinderi and Theodora Papamitsou and Vasileios T. Papaliagkas},
journal = {International Journal of Molecular Sciences},
year = {2022},
doi = {10.3390/ijms23052687},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Archives of Biochemistry and Biophysics 2006
Preprint · OA
Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance
Free Radical Biology and Medicine 2016
Preprint · OA
Energy metabolism and inflammation in brain aging and Alzheimer’s disease
Biomolecules 2015
Open access · CC-BY
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Brain and Behavior 2020
Open access · CC-BY
Neurodegeneration in type 2 diabetes: Alzheimer's as a case study
Nutritional Psychiatry 2025
Open access · CC-BY
Chronobiology and Neurodegeneration: The Role of Melatonin in Alzheimer's Disease
Journal of Alzheimer s Disease 2010
Open access · CC-BY